Page 1 of Clinical Trials for New River Pharmaceuticals [SPONSOR-COLLABORATORS], 6 Total Matches
- 1CompletedLast Updated: May 23, 2011Condition(s): Attention Deficit Disorder With Hyperactivity
- 2CompletedLast Updated: November 1, 2007Condition(s): Attention Deficit Disorder With Hyperactivity; Amphetamine-Related Disorders; Substance-Related Disorders
- 3CompletedLast Updated: July 1, 2009Condition(s): Attention Deficit Hyperactivity Disorder; Attention Deficit Disorders With Hyperactivity; Attention Deficit Hyperactivity Disorders
- 4CompletedLast Updated: March 31, 2011Condition(s): Attention Deficit Hyperactivity Disorder; Attention Deficit Disorders With Hyperactivity; Attention Deficit Hyperactivity Disorders
- 5CompletedLast Updated: November 1, 2007Condition(s): Attention Deficit Disorder With Hyperactivity; Amphetamine-Related Disorders; Substance-Related Disorders
- 6CompletedLast Updated: June 20, 2011Condition(s): Attention Deficit Hyperactivity Disorder
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=New+River+Pharmaceuticals
